Skip to main content
HairCited

Finasteride के लिए Androgenetic Alopecia

A

129 अध्ययनों (16 meta-analyses, 13 RCTs) पर आधारित, में कुल 18,623 प्रतिभागियों के साथ। 106/129 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dfinasteride\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Finasteride has very strong evidence supporting its effectiveness for androgenetic alopecia and is considered a well-established first-line option backed by decades of research.

  • 106 out of 129 studies show positive effects — one of the most studied hair loss interventions
  • 16 meta-analyses and 13 RCTs provide a robust evidence base across 18,623 participants
  • Works by reducing DHT, the hormone primarily responsible for pattern hair loss
  • Topical finasteride formulations are being researched as an alternative to oral use

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: women with androgenetic alopecia (female pattern hair loss)

Review
The Over-The-Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); बनाम: Placebo प्रभाव: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi बनाम: Placebo प्रभाव: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None बनाम: Placebo प्रभाव: None None
randomized controlled trial n=45 Open-label
Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of …
Dose: Group A: 5% Minoxidil alone; Group B: 5% Minoxidil + Finasteride; Group C: Microneedling + 5% Minoxi बनाम: Placebo प्रभाव: Hair density and hair shaft diameter increased in all groups; Group C superior to Group A in Norwood p<0.01

Key Statistics

206

अध्ययन

24777

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Aesthetic plastic surgery 2025 14 उद्धरण
Expert opinion on … 2025 11 उद्धरण
Anais brasileiros de … 2025 7 उद्धरण
Drug design, development … 2025 7 उद्धरण
International journal of … 2025 5 उद्धरण
Therapeutic delivery 2025 4 उद्धरण
Journal of cosmetic … 2025 3 उद्धरण
European journal of … 2025 3 उद्धरण
Journal of cutaneous … 2025 2 उद्धरण
Frontiers in pharmacology 2025 2 उद्धरण
Australian prescriber 2025 2 उद्धरण
Skin appendage disorders 2025 1 उद्धरण
Nature reviews. Disease … 2025
Annals of dermatology 2025
International journal of … 2024 39 उद्धरण
Biomedicines 2024 17 उद्धरण
Indian journal of … 2024 14 उद्धरण
Dermatology (Basel, Switzerland) 2024 14 उद्धरण
Journal of cosmetic … 2024 11 उद्धरण
Journal of clinical … 2024 10 उद्धरण
Facial plastic surgery … 2024 8 उद्धरण
American family physician 2024 8 उद्धरण
Photodermatology, photoimmunology & … 2024 8 उद्धरण
Journal of cosmetic … 2024 8 उद्धरण
International journal of … 2024 5 उद्धरण
Drugs 2023 221 उद्धरण
JAAD international 2023 80 उद्धरण
Clinical, cosmetic and … 2023 58 उद्धरण
American journal of … 2023 41 उद्धरण
Anais brasileiros de … 2023 29 उद्धरण
Dermatology and therapy 2023 23 उद्धरण
Journal of the … 2023 20 उद्धरण
International journal of … 2023 5 उद्धरण
Journal der Deutschen … 2023 5 उद्धरण
Journal of cosmetic … 2023 3 उद्धरण
BMJ case reports 2023 2 उद्धरण
Clinics in plastic … 2023 1 उद्धरण
International journal of … 2023 1 उद्धरण
The Journal of … 2022 65 उद्धरण
Faculty reviews 2022 44 उद्धरण
Dermatologic therapy 2022 41 उद्धरण
Pharmaceutics 2022 36 उद्धरण
The Korean journal … 2022 19 उद्धरण
Dermatologic therapy 2022 14 उद्धरण
Archivos espanoles de … 2022 9 उद्धरण
Cureus 2022 3 उद्धरण
Facial plastic surgery … 2022
Journal of cutaneous … 2021 44 उद्धरण
Journal of the … 2021 42 उद्धरण
Expert opinion on … 2020 147 उद्धरण
Fertility and sterility 2020 94 उद्धरण
Neurobiology of stress 2020 72 उद्धरण
General and comparative … 2020 37 उद्धरण
Dermatologic therapy 2020 34 उद्धरण
American journal of … 2020 24 उद्धरण
Facial plastic surgery … 2020 15 उद्धरण
Dermatologic clinics 2020 15 उद्धरण
Alternative therapies in … 2020 11 उद्धरण
Journal of cosmetic … 2019 100 उद्धरण
Journal of the … 2019 95 उद्धरण
Journal of the … 2019 55 उद्धरण
Assay and drug … 2019 19 उद्धरण
The aging male … 2019 19 उद्धरण
International journal of … 2018 129 उद्धरण
Indian journal of … 2018 79 उद्धरण
Lasers in medical … 2018 75 उद्धरण
Expert opinion on … 2018 38 उद्धरण
Journal of cosmetic … 2018 13 उद्धरण
Endocrine 2017 442 उद्धरण
JAMA dermatology 2017 121 उद्धरण
Current clinical pharmacology 2017 62 उद्धरण
Actas dermo-sifiliograficas 2017 17 उद्धरण
Deutsches Arzteblatt international 2016 99 उद्धरण
The Cochrane database … 2016 18 उद्धरण
Indian journal of … 2016 8 उद्धरण
The Medical clinics … 2015 66 उद्धरण
Seminars in cutaneous … 2015 27 उद्धरण
Current problems in … 2015 8 उद्धरण
Der Internist 2015
Lasers in surgery … 2014 243 उद्धरण
Journal of cutaneous … 2014 168 उद्धरण
Expert opinion on … 2014 57 उद्धरण
Current opinion in … 2014 43 उद्धरण
Journal of drugs … 2014 26 उद्धरण
Giornale italiano di … 2014 8 उद्धरण
Indian journal of … 2013 196 उद्धरण
Dermatologic clinics 2013 78 उद्धरण
Journal of cosmetic … 2013 62 उद्धरण
Facial plastic surgery … 2013 16 उद्धरण
International journal of … 2013
Skin therapy letter 2012 100 उद्धरण
The British journal … 2011 96 उद्धरण
Expert opinion on … 2010 264 उद्धरण
Current opinion in … 2009 54 उद्धरण
Seminars in cutaneous … 2009 4 उद्धरण
American family physician 2009
Nihon rinsho. Japanese … 2008 6 उद्धरण
Endocrinology and metabolism … 2007 33 उद्धरण
Acta dermatovenerologica Alpina, … 2005
Revue medicale de … 2004
Praxis 2003 28 उद्धरण
American family physician 2003
Molecular and cellular … 2002
American journal of … 2000 18 उद्धरण
Southern medical journal 2000
International journal of … 1999
American family physician 1999
Journal of the … 1999
Current pharmaceutical design 1999
Journal of cutaneous … 1999
Dermatologic clinics 1998 121 उद्धरण
Annales de dermatologie … 1997

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

hairloss:
1 mg/day oral

अधिकतम सीमा: 5 mg/day (BPH dose)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Neutral --
None -- Neutral --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Group A: 5% Minoxidil alone; Group B: 5% Minoxidil + Finasteride; Group C: Microneedling + 5% Minoxi -- Positive 45
None -- Positive --
various across included studies (2015-2024) -- Positive --

सेवन का सर्वोत्तम समय: Once daily at the same time, with or without food

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Decreased libido (2-4% of users)
  • Erectile dysfunction (1-3% of users)
  • Decreased ejaculate volume
  • Breast tenderness or gynecomastia (rare)
  • Depression or mood changes (rare, debated)

ज्ञात अंतःक्रियाएँ

  • No significant drug-drug interactions identified
  • May affect PSA test results (reduces PSA by ~50%)
  • Contraindicated in pregnancy (Category X teratogen)

सहनीय अधिकतम सेवन: 5 mg/day (BPH dose)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Finasteride help with Androgenetic Alopecia?
Based on 206 studies with 24,777 participants, there is strong evidence from multiple clinical trials that Finasteride may support Androgenetic Alopecia management. Our evidence grade is A (Strong Evidence).
How much Finasteride should I take for Androgenetic Alopecia?
Studies have used various dosages. A commonly studied range is 1 mg/day oral. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Finasteride?
Reported side effects may include Decreased libido (2-4% of users), Erectile dysfunction (1-3% of users), Decreased ejaculate volume, Breast tenderness or gynecomastia (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Finasteride and Androgenetic Alopecia?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 206 peer-reviewed studies with 24,777 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Androgenetic Alopecia

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।